-
Fresenius' Spanish Agreement - Analyst Blog
Monday, January 24, 2011 - 5:49pm | 379Fresenius Medical Care (FMS), the largest global player in dialysis-related services, recently arrived at an agreement with the public health department of the Murcia region of Spain. This constitutes Spain's first-ever complete dialysis care and performance-linked reimbursement model. Under...
-
Earnings Preview: Quest Diagnostics - Analyst Blog
Monday, January 24, 2011 - 5:34pm | 901Quest Diagnostics (DGX) is scheduled to release its fourth quarter and fiscal 2010 earnings on January 25, 2011 before the market opens. The company is expected to earn 91 cents during the quarter on $1,801 million in revenues and $3.98 during the fiscal on $7,346 million in revenues, according...
-
BioScrip Downgraded to Underperform - Analyst Blog
Monday, January 24, 2011 - 3:01pm | 450Recently, we downgraded BioScrip (BIOS) to Underperform with a target price of $4.50. BioScrip posted a disappointing quarter based on higher costs and tax. Although revenues grew at double-digit, driven by the CHS acquisition, the organic growth was below expectation. BioScrip has been...
-
BioScrip Downgraded to Underperform - Analyst Blog
Monday, January 24, 2011 - 2:12pm | 450Recently, we downgraded BioScrip (BIOS) to Underperform with a target price of $4.50. BioScrip posted a disappointing quarter based on higher costs and tax. Although revenues grew at double-digit, driven by the CHS acquisition, the organic growth was below expectation. BioScrip has been...
-
Market Roundup (HAL, GXDX, NVS, INTC, AXP, CSX, TXN)
Monday, January 24, 2011 - 12:28pm | 309Shares of Halliburton Co (NYSE: HAL) gained about 2% after the company reported its Q4 profit at $0.66 per share, up from $0.27 per share, in the year-ago period. The company's operating income surged to $0.68 per share, from $0.27 per share. HAL reported its revenue at $5.16 billion, versus $3.69...
-
Top Narrow Based Indexes For January 24 (CLDA, LDK, GXDX)
Monday, January 24, 2011 - 12:09pm | 218By 11:05 am, the Dow Jones Industrial Average was up 57.48 points, or 0.48%, to 11,929.32, while the broader Standard & Poor's 500 index had gained 3.50 points, or 0.27%. The NASDAQ composite index rose 10.45 points, or 0.39%. Some of the narrow based indexes driving the markets are Genetic...
-
Benzinga's Volume Movers (GXDX, CLDA, HUGH, LPHI)
Monday, January 24, 2011 - 11:48am | 182Genoptix Inc (NASDAQ: GXDX) shares moved up 25.76% to $24.85 at 10:46 am. The volume of GXDX shares traded was 12456% higher than normal. Novartis AG (NYSE: NVS) announced its plans to buy GXDX for $470 million, or $25 per share, representing a 39% premium over GXDX's share value on December 13,...
-
Morning Market Movers (CLDA, OCCF, SSCC, GXDX)
Monday, January 24, 2011 - 10:54am | 167Clinical Data Inc (NASDAQ: CLDA) climbed 55.22% to $23.33 at 9:50 am. The Food and Drug Administration (FDA) approved the CLDA's depression drug Viibryd. Optical Cable Corporation (NASDAQ: OCCF) shares surged 35.14% to $5.00. OCCF reported 31.1% y/y surge in its Q4 net sales. Smurfit-Stone...
-
Jefferies Reviews Healthcare Industry (AFAM, GTIV, HGR, IPCM, RDNT)
Monday, January 24, 2011 - 10:41am | 138Jefferies took a look at the healthcare industry in a research report published this morning. In the report, Jefferies states, "Healthcare service stocks will likely remain under pressure as concerns over utilization trends and Medicaid reimbursement risk build and as ST investors wait for Q4...
-
AMN Announces Managed Services Agreement with PeaceHealth
Monday, January 24, 2011 - 9:46am | 110AMN Healthcare Services, Inc. (NYSE: AHS) announced that it has entered into a Managed Services Program agreement with PeaceHealth to provide nursing and allied contingent healthcare clinical professionals for its six-hospital system that serves communities across Alaska, Washington and Oregon....
-
Benzinga's Top Pre-Market NASDAQ Gainers (CLDA, GXDX, NVDA, ATPG)
Monday, January 24, 2011 - 9:20am | 157Clinical Data Inc (NASDAQ: CLDA) rose 43.25% to $21.53 in the pre-market session. The Food and Drug Administration (FDA) approved the CLDA's depression drug Viibryd. Genoptix Inc (NASDAQ: GXDX) added 25.81% to $24.86 in the pre-market session. Novartis AG (NYSE: NVS) announced its plans to acquire...
-
American Shared Hospital Services Signs Teaming Agreements
Monday, January 24, 2011 - 9:09am | 78American Shared Hospital Services (NYSE: AMS) announced today that it has entered into a teaming agreement with Turner Construction Company, NBBJ LP, Garfield Traub, and Baines Group, Inc. to provide total solutions for proton therapy center development clients. Under the teaming agreement, AMS...
-
Walgreen Upgraded to Outperform - Analyst Blog
Friday, January 21, 2011 - 5:31pm | 584Recently, we upgraded Walgreen (WAG) to Outperform with a target price of $50.00. Walgreen's first quarter fiscal 2011 results have been encouraging despite the current economic uncertainty, which is having an impact on discretionary spending and reimbursement issues. Revenues rose 6% year over...
-
Walgreen Upgraded to Outperform - Analyst Blog
Friday, January 21, 2011 - 4:50pm | 584Recently, we upgraded Walgreen (WAG) to Outperform with a target price of $50.00. Walgreen's first quarter fiscal 2011 results have been encouraging despite the current economic uncertainty, which is having an impact on discretionary spending and reimbursement issues. Revenues rose 6% year over...
-
Stocks Where 50-DMA Is Crossing 200-DMA (BRLI, KBH, MNI, EWP)
Friday, January 21, 2011 - 3:42pm | 268A number of stocks are seeing there 50-Day moving average cross over the 200-Day moving average in Friday's trading session. This indicates that the stock is in an uptrend and some traders put considerable credence in this indicator. The first name that we have today is Bio-Reference Laboratories...